You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CORT Sale Disclosure
Mokari Atabak · SEC Form 4 · Filed Jun 3, 2026
Sale
Calculated transaction value
$2.8M
Mokari Atabak Chief Financial Officer
CORT
Transaction date
Jun 1, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 2 days later
CORT daily price context
Close on/before transaction
$70.44
Jun 1, 2026
First close after public filing
$74.89
Jun 4, 2026
30-day return after filing
+22.33%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 40,000 shares @ $70
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-256011
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$3.64M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Corcept Therapeutics Inc CORT | Disposition | Jun 2, 2026 | $27.82K |
| Corcept Therapeutics Inc CORT | Exercise | Jun 1, 2026 | $770.4K |
| Corcept Therapeutics Inc CORT Current | Sale | Jun 1, 2026 | $2.8M |
| Corcept Therapeutics Inc CORT | Award | Jun 1, 2026 | $44.66K |
| Corcept Therapeutics Inc CORT | Award | Jun 1, 2026 | $0 |
| Corcept Therapeutics Inc CORT | Exercise | Jun 1, 2026 | $0 |